Cold Spring Harbor perspectives in biology最新文献

The calcium ion (Ca²⁺) is a pivotal second messenger orchestrating diverse cellular functions, including metabolism, signaling, and apoptosis. Membrane contact sites (MCSs) are critical hubs for Ca²⁺ exchange, enabling rapid and localized signaling across cell compartments. Well-characterized interfaces, such as those between the endoplasmic reticulum (ER) and mitochondria and ER-plasma membrane (PM), mediate Ca²⁺ flux through specialized channels. Less understood, yet significant, contacts involving Golgi, lysosomes, peroxisomes, and the nucleus further expand the landscape of intracellular Ca²⁺ signaling. These organelles are engaged in Ca²⁺ homeostasis mainly through their MCS, but the molecular players and the mechanisms regulating the process of Ca²⁺ transfer remain incompletely elucidated. This review provides a comprehensive overview of Ca²⁺ signaling across diverse MCS, emphasizing understudied organelles and the need for further investigation to uncover novel therapeutic opportunities.

Cell migration plays a central role in a wide range of physiological, developmental, and disease-related processes. Studies using single-cell models, such as Dictyostelium discoideum, have provided important insights into the molecular principles underlying this process. Migrating cells exhibit a polarized morphology, with actin-rich protrusions at the leading edge driving forward motion and an actomyosin network at the trailing edge enabling retraction. While actin polymerization and direct cytoskeletal regulators are essential, a complex network of signaling molecules also play a critical role in cell migration. Initially viewed as part of the directional sensing machinery in guided migration, this signaling network is now also recognized as an integral component of the motility module itself. Its spontaneous activity coordinates with cytoskeletal reorganization, enabling cell migration even in the absence of external cues. This review highlights key cytoskeletal and signaling molecules involved in leading-edge protrusion formation, with an emphasis on findings from Dictyostelium studies. We also discuss recent advances in understanding how these cytoskeletal and signaling molecules organize into excitable networks to regulate cell motility.

Telomeres, the long nucleotide repeats, and protein complex at chromosome ends, are central to genomic integrity. Telomere length (TL) varies widely between populations due to germline genetics, environmental exposures, and other factors. Very short telomeres caused by pathogenic germline variants in telomere maintenance genes cause the telomere biology disorders, a spectrum of life-threatening conditions including bone marrow failure, liver and lung disease, cancer, and other complications. Cancer predisposition with long telomeres is caused by rare pathogenic germline variants in components of the shelterin telomere protection protein complex and associated primarily with elevated risk of melanoma, thyroid cancer, sarcoma, and lymphoproliferative malignancies. In the middle, studies of the general population at risk of common illnesses, such as cardiovascular disease and cancer, have found statistically significant differences in TL but uncertain clinical applicability. This work reviews connections between telomere biology and human disease focusing on similarities and differences across the phenotypic spectrum.

This paper argues that the historiography of genetics ∼1900, the formation period of modern science, is too narrow. It lacks attention to plant breeding. Perhaps this omission also narrows the present understanding of fundamental ideas like the genotype/phenotype distinction and the gene concept? There is a mythical story still told in textbooks and at anniversaries: As modern genetics started with the rediscovery of Mendel's laws in 1900, a fateful controversy over continuous or discontinuous variation of heredity between biometricians and Mendelians. Discontinuity appeared as a threat to the Darwinian theory of evolution by natural selection. Only by the 1920s was the problem solved by a theory of population genetics founded on the chromosome theory of heredity.¹ However, in plant breeding ∼1900 ideas of heredity and evolution were closely intertwined, and the combination of discontinuous heredity with continuous Darwinian evolution was an obvious option.

Calcium is essential for cellular homeostasis, orchestrating a vast array of physiological processes through tightly regulated storage, flux, and signaling pathways. Dysregulation of calcium homeostasis disrupts these finely tuned processes, leading to aberrant signaling that contributes to cancer progression. Beyond its role in cellular dysfunction, calcium also regulates the metabolic reprogramming in cancer cells, enabling them to adapt their metabolism to support tumor growth, survival, and resistance. Despite its fundamental role, direct therapeutic targeting of calcium signaling in cancer remains elusive. This review explores the intricate cross talk between calcium signaling and cancer metabolism, dissecting how distinct calcium dynamics drive adaptive oncogenic adaptations. Deciphering this interplay may reveal therapeutic opportunities that leverage calcium-dependent metabolic vulnerabilities in cancer. Given its broad influence, calcium signaling regulation could serve as a multitargeting strategy for anticancer therapy, broadening the range of potential therapeutic interventions.

Somatic mutations arise in normal tissues and precursor lesions, often targeting cancer-driver genes involved in cell cycle regulation. Most checkpoint-mutant clones, however, remain dormant throughout an individual's lifetime and seldom progress to malignancy, implying the presence of protective mechanisms that limit their expansion and malignant transformation. One such safeguard is telomere crisis-a potent tumor-suppressive barrier that eliminates cells lacking functional checkpoints and evading p53- and pRb-mediated surveillance. While the genomic instability unleashed during telomere crisis can drive clonal evolution, cell death is typically the dominant outcome, with only a rare subset of cells escaping elimination to initiate malignancy. Recognizing the dual role of telomere crisis-suppressing tumor initiation while enabling clonal evolution-is essential for understanding early cancer development and designing strategies to eliminate tumor-initiating cells.

Three-dimensional (3D) printing can be beneficial to tissue engineers and the regenerative medicine community because of its potential to rapidly build elaborate 3D structures from cellular and material inks. However, predicting changes to the structure and pattern of printed tissues arising from the mechanical activity of constituent cells is technically and conceptually challenging. This perspective is targeted to scientists and engineers interested in 3D bioprinting, but from the point of view of cells and tissues as mechanically active living materials. The dynamic forces generated by cells present unique challenges compared to conventional manufacturing modalities but also offer profound opportunities through their capacity to self-organize. Consideration of self-organization following 3D printing takes the design and execution of bioprinting into the fourth dimension of cellular activity. We therefore propose a framework for dynamic bioprinting that spatiotemporally guides the underlying biology through reconfigurable material interfaces controlled by 3D printers.

The natural ends of chromosomes resemble double-strand breaks (DSBs), which would activate the DNA damage response (DDR) pathway without the protection provided by a specialized protein complex called shelterin. Over the past decades, extensive research has uncovered the mechanism of action and the high degree of specialization provided by the shelterin complex to prevent aberrant activation of DNA repair machinery at chromosome ends in somatic cells. However, recent findings have revealed striking differences in the mechanisms of end protection in stem cells compared to somatic cells. In this review, we discuss what is known about the differences between stem cells and somatic cells regarding chromosome end protection.

Basic research that established how the cell cycle is regulated has been critical to our understanding of carcinogenesis and paved the way for new treatments like palbociclib and ribocilib. Mitosis was first observed almost 150 years ago, and the phases of the cell cycle were defined midway through the twentieth century. Subsequent studies in yeast, frogs, mice, and human cells identified the molecular machinery that controls entry into the cell cycle, including cyclin-dependent kinases, their regulators, and the product of the retinoblastoma (RB) gene. In this excerpt from his forthcoming book on the history of cancer research, Joe Lipsick looks back at the work that discovered these key molecules and mapped the RB pathway that controls the G₁/S transition.

Telomere function is critical for genomic stability; in the context of a functional TP53 response, telomere erosion leads to a G₁/S cell-cycle arrest and the induction of replicative senescence, a process that is considered to underpin the ageing process in long-lived species. Abrogation of the TP53 pathway allows for continued cell division, telomere erosion, and the complete loss of telomere function; the ensuing genomic instability facilitates clonal evolution and malignant progression. Telomeres display extensive length heterogeneity in the population that is established at birth, and this affects the individual risk of a broad range of diseases, including cardiovascular disease and cancer. In this perspective, I discuss telomere length heterogeneity at the levels of the population, individual, and cell, and consider how the dynamics of these essential chromosomal structures contribute to human disease.